# Topical Antifungal Drug Products for Over-the-Counter Human Use; Amendment of Final Monograph; Correction
> **Food and Drug Administration** · Final rule; correction. · Published 2002-03-15 · 67 FR 11571
## Document
- **Document number:** 02-6180
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 67 FR 11571
- **CFR reference:** 21 CFR 333
- **Publication date:** 2002-03-15
- **HHS docket:** Docket No. 96P-0460
## Abstract

The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of February 8, 2002 (67 FR 5942). The document amended the final monograph for over-the-counter (OTC) topical antifungal drug products to add the ingredient clotrimazole as generally recognized as safe and effective for the treatment of athlete's foot, jock itch, and ringworm. The document was inadvertently published with an incorrect docket number. This document corrects that error.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2002/03/15/02-6180/topical-antifungal-drug-products-for-over-the-counter-human-use-amendment-of-final-monograph)
---
*AI Analytics · CC0 1.0*